<!DOCTYPE html>
<html>
<head>
  <title>Ernest Arenas Lab</title>
  <meta charset="utf-8"/>
  <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.6/css/bootstrap.min.css" integrity="sha384-1q8mTJOASx8j1Au+a5WDVnPi2lkFfwwEAa8hDDdjZlpLegxhjVME1fgjWPGmkzs7" crossorigin="anonymous">
  <link href='https://fonts.googleapis.com/css?family=Roboto:300,400,700' rel='stylesheet' type='text/css'>
  <link rel="stylesheet" type="text/css" href="./css/main.css">
<!-- Google Analytics -->
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-99230053-1', 'auto');
  ga('send', 'pageview');

</script>
<!--End Google Analytics -->
</head>
<body>
  <header class="container">
	  <link rel="icon" href="/img/testicon.png">

    <div class="navigation">
      <ul>
        <li><a class="page-link" href="/">Home</a></li>
        <li><a class="page-link" href="/research/">Research</a></li>
        <li><a class="page-link" href="/publications/">Publications</a></li>
        <li><a class="page-link" href="/people/">People</a></li>
        <li><a class="page-link" href="/links/">Links</a></li>
      </ul>
    </div>
  </header>
  
	<p>&nbsp;</p>
	
	
<!-- LARGE TITLE BANNER -->	
	
  <section class="jumbotron">
    <div class="container">
      <div class="row text-center">
        <h1>Ernest Arenas Lab</h1>
        <p>&nbsp;</p>
        <h3>Karolinska Institutet</h3>	      
        <h4>Department of Medical Biochemistry and Biophysics</h4>
        <h4>Division of Molecular Neurobiology</h4>
      </div>
    </div>
  </section>
  
  <p>&nbsp;</p>
	
<!-- News post section -->	
  
  <div class="wrap">
    <div class="post">
      <div class="news">
        
<!-- Pinned headline -->
	      
<!--	
	<h2>Title</h2>
	  <ul class="posts">
            <li>
              <span class="post-link"><p><a href="___"</a></p></span>
	    </li>
	  </ul>
	      
        <p>&nbsp;</p>
-->	      
	    
<!-- End pinned headline -->	      
	      
        <h2>Lab News:</h2>
        <p>&nbsp;</p>
        <ul class="posts">
          
<!-- TO ADD NEWS ITEM, COPY AND PASTE TEMPLATE BELOW:	  

          <li>
            <span class="post-date">TYPE DATE HERE</span>
            <span class="post-link">POST TITLE HERE</span>
          </li>
          <div class="well">
            <li class="media">
              <div class="media-body">
                <img class="pull-left" style="margin-right:10px;" src="IMAGE FILE HERE" height="300px";>
                  <strong class="media-heading"><a href="LINK TO ARTICLE/NEWS HERE">TITLE FOR LINK HERE</a></strong>
                <p><small>SHORTHAND AUTHORS HERE</small></p>
                 <p>PARAGRAPH TEXT HERE</p>
                FOR ADDITIONAL LINKS INCLUDE LINES BELOW, OTHERWISE REMOVE
                <p><a href="LINK HERE">TITLE FOR LINK</a></p>
                <p><a href="LINK HERE">TITLE FOR LINK</a></p>
              </div>
             </li>
           </div>
           <p>&nbsp;</p>

:END TEMPLATE -->
<li>
            <span class="post-date">October 13, 2023</span>
            <span class="post-link">Two articles in the same issue of <u>Science</u> provide two new single cell atlases describing the development of the human midbrain and the subtypes of midbrain dopaminergic neurons in the adult human brain, respectively. These results are part of a true collaborative effort between <b>Sten Linnarsson</b> and <b>Ernest Arenas</b> groups, and part of a broader analysis of the human brain and of a large collection of articles published in Science and Science Advances simultaneously.</span>
          </li>
          <div class="well">
            <li class="media">
              <div class="media-body">
                <img class="pull-left" style="margin-right:10px;" src="/img/science.add7046-fa.jpg" height="300px";>
                  <strong class="media-heading"><a href="https://www.science.org/toc/science/382/6667">The Human brain cell census</a></strong>
                <p><small>Sten Linnarsson & Ernest Arenas</small></p>
		      
<div class="well">
              <li class="media">
                <div class="media-body">
                  <h4><b><a href="https://pubmed.ncbi.nlm.nih.gov/37824650/" target="_blank">Comprehensive cell atlas of the first-trimester developing human brain</a></b></h4>
                  <p></p>
                  <small>Emelie Braun<sup>&#8224;</sup>, Miri Danan-Gotthold<sup>&#8224;</sup>, Lars Borm, <b>Ka Wai Lee</b>, Elin Vinsland, Peter Lonnerberg, Lijuan Hu, Xiaofei Li, Xiaoling He, Zaneta Andrusivova, Joakim Lundeberg, Roger Barker, <b>Ernest Arenas</b><sup>&#8224;</sup>, Erik Sundstrom<sup>&#8224;</sup>, Sten Linnarsson*</small>
                  <p></p>
                  <p>Published in <strong><u>Science</u></strong><br>
                  October 13, 2023. DOI: <a href="https://doi.org/10.1126/science.adf1226" target="_blank">10.1126/science.adf1226</a></p>
                </div>
              </li>
            </div>	

<div class="well">
              <li class="media">
                <div class="media-body">
                  <h4><b><a href="https://pubmed.ncbi.nlm.nih.gov/37824663/" target="_blank">Transcriptomic diversity of cell types across the adult human brain</a></b></h4>
                  <p></p>
                  <small>imberly Siletti<sup>&#8224;</sup>, Rebecca Hodge#, Alejandro Mossi Albiach#, <b>Ka Wai Lee</b>, Song-Lin Ding, Lijuan Hu,  Peter Lönnerberg, Trygve Bakken, Tamara Casper, Michael Clark, Nick Dee, Jessica Gloe, Daniel Hirschstein, Nadiya V Shapovalova, C Dirk Keene, Julie Nyhus, Herman Tung, Anna Marie Yanny, <b>Ernest Arenas</b>, Ed S Lein, Sten Linnarsson*</small>
                  <p></p>
                  <p>Published in <strong><u>Science</u></strong><br>
                  October 13, 2023. DOI: <a href="https://doi.org/10.1126/science.add7046" target="_blank">10.1126/science.add7046</a></p>
                </div>
              </li>
            </div>		      
		      
		      
              </div>
             </li>
           </div>
           <p>&nbsp;</p>

		
<li>
  <span class="post-date">June 30, 2020</span>
  <span class="post-link">NEWS AND VIEWS on new method to convert astrocytes to midbrain dopaminergic Neurons in <u>Nature</u></span>
</li>
<div class="well">
  <li class="media">
    <div class="media-body">
       <strong class="media-heading"><a href="https://www.nature.com/articles/d41586-020-01817-4">Method to combat Parkinson’s disease by astrocyte-to-neuron conversion</a></strong>
          <p><small>Arenas E</small></p>
    </div>
  </li>
</div>
		
<p>&nbsp;</p>	



<li>
  <span class="post-date">June 30, 2020</span>
  <span class="post-link">Review article on midbrain dopaminergic Neuron Development at the Single Cell Level in <u>Frontiers in Cell and Developmental Biology</u></span>
</li>
<div class="well">
  <li class="media">
    <div class="media-body">
       <strong class="media-heading"><a href="https://www.frontiersin.org/articles/10.3389/fcell.2020.00463/full">Midbrain Dopaminergic Neuron Development at the Single Cell Level: In vivo and in Stem Cells</a></strong>
          <p><small>Ásgrímsdóttir ES, and Arenas E</small></p>
    </div>
  </li>
</div>
		
<p>&nbsp;</p>	
		
		
		
<li>
          <span class="post-date">May 31, 2020</span>
          <span class="post-link">Collaborative article with the group of Jens Hjerling-Leffler on genetic identification of cell types underlying brain complex traits of Parkinson's disease in <u>Nature Genetics</u></span>
</li>
  <div class="well">
     <li class="media">
       <div class="media-body">
          <strong class="media-heading"><a href="https://www.nature.com/articles/s41588-020-0610-9">Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson’s disease</a></strong>
          <p><small>Bryois, J et al.</small></p>
       </div>
     </li>
   </div>
	
<p>&nbsp;</p>
		
		
		<li>
          <span class="post-date">May 5, 2020</span>
	<span class="post-link">Original article in <u>Cell Reports</u> on the role of <i>Srebf1</i> in controlling midbrain dopaminergic neurogenesis</span>
        </li>
        <div class="well">
          <li class="media">
            <div class="media-body">
              <!--<img class="pull-left" style="margin-right:10px;" src="/img/csf.png" width="300px";> -->
                <strong class="media-heading"><a href="https://www.cell.com/cell-reports/fulltext/S2211-1247(20)30550-7"><i>Srebf1</i> Controls Midbrain Dopaminergic Neurogenesis</a></strong>
                <p><small>Toledo EM et al.</small></p>
		<div id="featureimage">
		  <img src="/img/srebf1ms.jpg"; align="middle"; width="600px";>
		</div>
                <p>Liver X receptors (LXRs) and their ligands are potent regulators of midbrain dopaminergic (mDA) neurogenesis and differentiation. However, the molecular mechanisms by which LXRs control these functions remain to be elucidated. Here, we perform a combined transcriptome and chromatin immunoprecipitation sequencing (ChIP-seq) analysis of midbrain cells after LXR activation, followed by bioinformatic analysis to elucidate the transcriptional networks controlling mDA neurogenesis. Our results identify the basic helix-loop-helix transcription factor sterol regulatory element binding protein 1 (SREBP1) as part of a cluster of proneural transcription factors in radial glia and as a regulator of transcription factors controlling mDA neurogenesis, such as Foxa2. Moreover, loss- and gain-of-function experiments in vitro and in vivo demonstrate that Srebf1 is both required and sufficient for mDA neurogenesis. Our data, thus, identify Srebf1 as a central player in mDA neurogenesis.
                </p>   
              </div>
            </li>
          </div>
		
<p>&nbsp;</p>
		
		
<li>
          <span class="post-date">April 1, 2020</span>
          <span class="post-link">NEWS: ERC Advanced Grant, <b>A PRECISION CELL REPLACEMENT STRATEGY FOR  PARKINSON’S DISEASE</b>, has been awarded to Ernest Arenas.<span>
</li>
        <div class="well">
          <li class="media">
	      <div class="media-body">
           
		      <div id="featureimage">
                <img class="pull-left" style="margin-right:10px;" src="/img/ERC.png" width="300px";>
              </div>
	   	    
              <p></p>
	
              <p><b>Summary of the project:</b>
		By mapping the dopaminergic cells, which are attacked and lost in the brain of patient with Parkinson's disease, at a molecular level using single-cell RNA sequencing, amongst other tools, our research group hopes to have sufficient information to create new ones, either by using stem cells that are then transplanted into the patient, or by reprogramming existing brain cells in vivo. The project can lead to more exact methods involving designing the right cell types for therapeutic intervention from the start.      
	      <br>
	      <br>
       		<strong class="media-heading"><a href="https://erc.europa.eu/news/erc-2019-advanced-grants-results">More information</a></strong>      
	      <br>
	      <br>
		<strong class="media-heading"><a href="https://news.ki.se/erc-advanced-grant-for-the-design-of-brain-cells-to-combat-parkinsons-disease">KI press release</a></strong>
	      </p>
            </div>
          </li>
        </div>
		
		
<p>&nbsp;</p>
		
<li>
            <span class="post-date">March 9, 2020</span>
            <span class="post-link">New Postdoctoral Researcher Positions Available.</span>
</li>
          <div class="well">
            <li class="media">
              <div class="media-body">
	<!--       
		<img class="pull-left" style="margin-right:10px;" src="IMAGE FILE HERE" height="300px";>
	-->
	
<p>
	The Arenas lab is looking for <u>Postdoctoral researchers </u>in the following areas:
</p>
		      
<li>
<p><u><strong><span style="color: #ff0000;">OPEN NOW</span></strong></u><strong><span style="color: #ff0000;">. Deadline March 25<sup>th</sup></span></strong>.
<br />&#8220;<strong>Single nuclei RNA-sequencing of Parkinson&#8217;s disease and cell replacement therapy</strong>&#8220;</p>
</li>
		     
<p>
All applications are to be submitted via the <strong>Karolinska Institute web recruitment system</strong>.
</p>
<p>
Apply here: <u><a href="https://ki.varbi.com/en/what:job/jobID:322776/">https://ki.varbi.com/en/what:job/jobID:322776/</a></u>
</p>	
	
<p>
	<strong>Requirements:</strong>
	We are looking for candidates with experience in single-cell/nuclei technologies (such as 10X genomics, ATAC-seq or in situ transcriptomics), single cell data analysis, computational biology tools (Linux, R, Python), imaging (in situ hybridization and confocal microscopy), molecular biology, FACS and previous work in the area of neuroscience. Experience in working with human pluripotent stem cells, gene editing, cellular reprogramming, genetics and epigenetics and/or previous work on midbrain development and/or neurodegenerative diseases, such as PD, will be considered as additional merits.
</p>
<p>
	<strong>Project:</strong>
	Work in this project will involve the use of diverse single cell technologies and bioinformatics tools in order to profile and define PD and cell replacement strategies for PD at the single cell level. Our overall goal is to understand disease mechanisms and develop better cell replacement therapies for PD.
	<br/>
</p>
<p>
	<strong>Documents</strong> to be submitted (English or Swedish):
</p>
		      
<ul>
	<li>A complete curriculum vitae, including date of the thesis defense, title of the thesis, previous academic positions, academic title, current position, academic distinctions, and committee work</li>
	<li>A complete list of publications</li>
	<li>A summary of current work (no more than one page)</li>
	<li>A personal letter with motivation</li>
	<li>The name, e-mail and phone of two recent group leaders to provide reference letters</li>
</ul>
<br />
<br />		      
<p>
   <strong>NEW POSITIONS COMING SOON:</strong>
</p>
<ol>
 <li><p>Position in &#8220;<strong>Reprogramming astrocytes into disease resistant dopaminergic neurons</strong>&#8220;</p></li>
 <li><p>Position in &#8220;<strong>Computational biology/Bioinformatics analysis of single cell data in Parkinson&#8217;s disease and regenerative medicine</strong>&#8220;</p></li>
 </ol>	
		      
<p>	
	<strong>For more information, please contact </strong>
	<u><a href="mailto:ernest.arenas@ki.se">ernest.arenas@ki.se</a></u>
</p>	
<!--
          </div>
-->
        </li>
       </div>
		 
		
<p>&nbsp;</p>
		

<li>
          <span class="post-date">January 1, 2020</span>
          <span class="post-link">NEWS: A New Horizon 2020 project of the EU, <b>Novel Strategies for Cell-based Neural Reconstruction</b> (<b>NSC-Reconstruct</b>), has been granted to Ernest Arenas as a partner.<span>
</li>
        <div class="well">
          <li class="media">
	      <div class="media-body">
            <!-- 
		      <div id="featureimage">
                <img src="/img/"; align="middle"; width="600px";>
              </div>
	      -->	    
              <p></p>
	
              <p><b>Summary of the project:</b>
		      Neurodegenerative diseases and brain injuries affect large patient groups and carry large unmet clinical needs. NSC-Reconstruct will respond to these needs by developing innovative therapies based on cell replacement, cell reprogramming and circuit reconstruction that have the potential to transform how we treat a wide range of neurological diseases and disorders. In this area of clinical science European research has generated groundbreaking knowledge that has resulted in a pioneering human embryonic stem cell-derived product that is now entering clinical trials for Parkinson’s Disease (PD). In NSC-Reconstruct we will move beyond the replacement of a single neuronal type towards future cell therapies with enhanced authenticity, functions and compositions. NSC-Reconstruct will address PD as an example of disorder for which single neuron replacement has been developed. Our focus in PD will be on incorporating improved cell types and on local network reconstruction. We will also work on repairing long distance networks such as those affected in Huntington’s disease and finally in restoring the complex networks and projections of the cerebral cortex to achieve effective repair in conditions known to affect this structure, such as trauma or stroke.
	      <br>
	      <br>
       		<strong class="media-heading"><a href="https://cordis.europa.eu/project/id/874758">More information: Horizon 2020</a></strong>      
	      <br>
	      <br>
		<strong class="media-heading"><a href="https://news.ki.se/generous-harvest-of-eu-funding-for-ki">KI press release</a></strong>
	      </p>
            </div>
          </li>
        </div>
           
<p>&nbsp;</p>
		  
<li>
 <span class="post-date">August 29, 2019</span>
 <span class="post-link">Collaborative article with the group of Charles ffrench-Constant on how Laminin &alpha;2 controls stem cell behaviour during midbrain dopaminergic neuron development in <u>Development</u></span>
</li>
<div class="well">
 <li class="media">
   <div class="media-body">
    <strong class="media-heading"><a href="https://dev.biologists.org/content/146/16/dev172668.long">Laminin &alpha;2 controls mouse and human stem cell behaviour during midbrain dopaminergic neuron development</a></strong>
    <p><small>Ahmed M et al.</small></p>
   </div>
 </li>
</div>
	
<p>&nbsp;</p>			
		
	<li>
          <span class="post-date">April 2, 2019</span>
	  <span class="post-link">Original article in <u>Nature Communications</u> on the transportation of Wnt5a in the cerebrospinal 
		  fluid via lipoporotein particles</span>
        </li>
        <div class="well">
          <li class="media">
            <div class="media-body">
              <!--<img class="pull-left" style="margin-right:10px;" src="/img/csf.png" width="300px";> -->
                <strong class="media-heading"><a href="https://www.nature.com/articles/s41467-019-09298-4">WNT5A is transported via lipoprotein particles in the cerebrospinal fluid to regulate hindbrain morphogenesis</a></strong>
                <p><small>Kaiser K et al.</small></p>
		<div id="featureimage">
		  <img src="/img/csf.png"; align="middle"; width="600px";>
		</div>
                <p>WNTs are lipid-modified proteins that control multiple functions in development and disease via short- and long-range 
			signaling. However, it is unclear how these hydrophobic molecules spread over long distances in the mammalian brain. 
			Here we show that WNT5A is produced by the choroid plexus (ChP) of the developing hindbrain, but not the 
			telencephalon, in both mouse and human. Since the ChP produces and secretes the cerebrospinal fluid (CSF), we 
			examine the presence of WNT5A in the CSF and find that it is associated with lipoprotein particles rather than 
			exosomes. Moreover, since the CSF flows along the apical surface of hindbrain progenitors not expressing Wnt5a, we 
			examined whether deletion of Wnt5a in the ChP controls their function and find that cerebellar morphogenesis is 
			impaired. Our study thus identifies the CSF as a route and lipoprotein particles as a vehicle for long-range 
			transport of biologically active WNT in the central nervous system.
                </p>   
              </div>
            </li>
          </div>
		
<p>&nbsp;</p>
		
     <li>
          <span class="post-date">April 1, 2019</span>
          <span class="post-link">NEWS: Ernest Arenas has been appointed Wallenberg Scholar from the Wallenberg Foundations in 2019.<span>
        </li>
        <div class="well">
          <li class="media">
	      <div class="media-body">
            <!-- 
		      <div id="featureimage">
                <img src="/img/czi.png"; align="middle"; width="600px";>
              </div>
	      -->	    
              <p></p>
	
              <p><b>Short description about the project:</b>
		      Parkinson’s disease is a very common neurodegenerative disorder. However, current therapies neither cure, nor slow down disease. Clinical trials have shown that it is possible to transplant and replace brain cells lost by the disease with cells from a fetus – but this approach poses several technical and ethical challenges. Ernest Arenas and his colleagues aim to identify the combination of genes controlling development of dopamine-producing neurons in the substantia nigra (SN), the cell type mainly affected by Parkinson’s disease. For this purpose they will use new methodologies such as single-cell RNA-sequencing and CRISPR/cas9 genome editing. They will apply the new knowledge to develop two methods to genetically control the formation of SN neurons.
	      <br>
	      <br>
       		<strong class="media-heading"><a href="https://kaw.wallenberg.org/en/press/twenty-two-excellent-researchers-chosen-be-wallenberg-scholars">More information: Knut and Alice Wallenberg Foundation</a></strong>      
	      <br>
	      <br>
		<strong class="media-heading"><a href="https://ki.se/en/news/they-are-the-2019-wallenberg-scholars">KI press release</a></strong>
	      </p>
            </div>
          </li>
        </div>
           
<p>&nbsp;</p>
		
		
	<li>
          <span class="post-date">Febuary 21, 2019</span>
          <span class="post-link">Collaborative article with the group of Per Uhlén on the role of a type of calcium channel Ca<sub>v</sub>3.2 in regulation of cortical neurogenesis in <u>Neuroscience</u></span>
        </li>
        <div class="well">
          <li class="media">
            <div class="media-body">
              <strong class="media-heading"><a href="https://www.sciencedirect.com/science/article/pii/S0306452219300351">The T-type Ca<sup>2+</sup> Channel Ca<sub>v</sub>3.2 Regulates Differentiation of Neural Progenitor Cells during Cortical Development via Caspase-3</a></strong>
              <p><small>Rebellato P, Kaczynska D et al.</small></p>
            </div>
          </li>
        </div>
	<p>&nbsp;</p>
		
	<li>
          <span class="post-date">January 18, 2019</span>
	  <span class="post-link">Original article in <u>Journal of Biological Chemistry</u> on role of Lxr ligands in dopaminergic neurogenesis and differentiation</span>
        </li>
        <div class="well">
          <li class="media">
            <div class="media-body">
              <img class="pull-left" style="margin-right:10px;" src="/img/EC-jbc.jpg" width="300px";>
                <strong class="media-heading"><a href="http://www.jbc.org/content/early/2019/01/17/jbc.RA118.005639.abstract">24(S),25-Epoxycholesterol and <i>cholesterol 24S-hydroxylase (CYP46A1)</i> overexpression promote midbrain dopaminergic neurogenesis <i>in vivo</i></a></strong>
                <p><small>Theofilopoulos S et al.</small></p>
                <p>The liver X receptors Lxrα/NR1H3 and Lxrβ/NR1H2 are ligand-dependent nuclear receptors critical for midbrain dopaminergic (mDA) neuron development. We previously found that 24(S),25-epoxycholesterol (24,25-EC), the most potent and abundant Lxr ligand in the developing mouse midbrain, promotes mDA neurogenesis in vitro. In this study, we demonstrate that 24,25-EC promotes mDA neurogenesis in an Lxr-dependent manner, in the developing mouse midbrain in vivo and also prevents toxicity induced by the Lxr inhibitor geranylgeranyl pyrophosphate. Furthermore, using MS we show that overexpression of human cholesterol 24S-hydroxylase (CYP46A1) increases the levels of both 24(S)-hydroxycholesterol (24-HC) and 24,25-EC in the developing midbrain, resulting in a specific increase in mDA neurogenesis in vitro and in vivo, but has no effect on occulomotor or red nucleus neurogenesis. 24-HC, unlike 24,25-EC, did not affect in vitro neurogenesis, indicating that the neurogenic effect of 24,25-EC on mDA neurons is specific. Combined, our results indicate that increased levels of 24,25-EC in vivo, by intracerebroventricular delivery in wild-type mice or by overexpression of its biosynthetic enzyme CYP46A1, specifically promote mDA neurogenesis. We propose that increasing the levels of 24,25-EC in vivo may be a useful strategy to combat the loss of mDA neurons in Parkinson’s disease.
                </p>   
              </div>
            </li>
          </div>
		  
<p>&nbsp;</p>	
		
	  
	<li>
          <span class="post-date">December 6, 2018</span>
          <span class="post-link">NEWS: Chan Zuckerberg Initiative award for Neurodegeneration Challenge Network to profile and define Parkinson's disease<span>
        </li>
        <div class="well">
          <li class="media">
            <div class="media-body">
              <div id="featureimage">
                <img src="/img/czi.png"; align="middle"; width="600px";>
              </div>
              <p></p>
	
              <p>The group of Ernest Arenas has been awarded a grant from CZI to systematically analyze and provide an unbiased understanding of the 
		      cell types and molecular mechanisms involved in Parkinson's disease.
		      The project will be performed in collaboration with Per Svenningsson (KI), Sten Linnarsson (KI), and Mats Nilsson (SU).
	      <br>
	      <br>
	        <strong class="media-heading"><a href="https://go.chanzuckerberg.com/NCN#!">More information: CZI Neurodegeneration Challenge Network</a></strong>
              <br>
	      <br>
		<strong class="media-heading"><a href="https://www.scilifelab.se/news/parkinsons-CZI/">SciLife Lab press release</a></strong>      
	      </p>
            </div>
          </li>
        </div>
           
<p>&nbsp;</p>
			
	<li>
          <span class="post-date">November 21, 2018</span>
          <span class="post-link">Collaborative article with the group of William Griffiths and Yuqin Wang on pathways of sterol metabolism in <u>Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids</u></span>
        </li>
        <div class="well">
          <li class="media">
            <div class="media-body">
              <strong class="media-heading"><a href="https://www.sciencedirect.com/science/article/pii/S1388198118303639?via%3Dihub8">Additional pathways of sterol metabolism: Evidence from analysis of Cyp27a1−/− mouse brain and plasma</a></strong>
              <p><small>Griffiths WJ et al.</small></p>
            </div>
          </li>
        </div>
		
<p>&nbsp;</p>
		
	<li>
          <span class="post-date">October 26, 2018</span>
          <span class="post-link">Collaborative article with the group of Per Uhlén on identity of a novel platinum resistance gene <i>COX7B</i> in <u>Cancer Medicine</u></span>
        </li>
        <div class="well">
          <li class="media">
            <div class="media-body">
              <strong class="media-heading"><a href="https://onlinelibrary.wiley.com/doi/full/10.1002/cam4.1828">Single‐cell RNA‐seq analysis reveals the platinum resistance gene COX7B and the surrogate marker CD63</a></strong>
              <p><small>Tanaka N, Katayama S, Reddy A et al.</small></p>
            </div>
          </li>
        </div>
		
<p>&nbsp;</p>
		
	<li>
          <span class="post-date">August 23, 2018</span>
	  <span class="post-link">Original article in <u>Stem Cell Reports</u> on role of R-Spondin 2 in dopaminergic neurogenesis and differentiation</span>
        </li>
        <div class="well">
          <li class="media">
            <div class="media-body">
              <img class="pull-left" style="margin-right:10px;" src="/img/rspo2.jpg" height="300px";>
                <strong class="media-heading"><a href="https://www.cell.com/stem-cell-reports/fulltext/S2213-6711(18)30319-9">The Matricellular Protein R-Spondin 2 Promotes Midbrain Dopaminergic Neurogenesis and Differentiation</a></strong>
                <p><small>Gyllborg D et al.</small></p>
                <p>The development of midbrain dopaminergic (mDA) neurons is controlled by multiple morphogens and transcription factors. However, little is known about the role of extracellular matrix proteins in this process. Here we examined the function of roof plate-specific spondins (RSPO1-4) and the floor plate-specific, spondin 1 (SPON1). Only RSPO2 and SPON1 were expressed at high levels during mDA neurogenesis, and the receptor LGR5 was expressed by midbrain floor plate progenitors. Surprisingly, RSPO2, but not SPON1, specifically promoted the differentiation of mDA neuroblasts into mDA neurons in mouse primary cultures and embryonic stem cells (ESCs). In addition, RSPO2 was found to promote not only mDA differentiation, but also mDA neurogenesis in human ESCs. Our results thus uncover an unexpected function of the matricellular protein RSPO2 and suggest an application to improve mDA neurogenesis and differentiation in human stem cell preparations destined to cell replacement therapy or drug discovery for Parkinson disease.
                </p>   
              </div>
            </li>
          </div>
		  
<p>&nbsp;</p>	
		  
<li>
          <span class="post-date">August 8, 2018</span>
          <span class="post-link">Collaborative article with the group of Sten Linnarsson on 
		    RNA sequencing of half a million cells in the mouse central nervous system published in <u>Cell</u></span>
        </li>
          <div class="well">
            <li class="media">
              <div class="media-body">
              <strong class="media-heading"><a href="https://www.sciencedirect.com/science/article/pii/S009286741830789X?via%3Dihub">Molecular Architecture of the Mouse Nervous System</a></strong>
              <p><small>Zeisel A et al.</small></p>
	      <p><a href="http://mousebrain.org/">Mousebrain.org</a>, wiki page for visualization of data</p>
               </div>
             </li>
           </div>
		
      <p>&nbsp;</p>	

		
	<li>
          <span class="post-date">July 3, 2018</span>
          <span class="post-link">Collaborative article with the group of Antonio del Sol on synergistic activity of transcription factors for subpopulation identity in <u>Nature Communications</u></span>
        </li>
        <div class="well">
          <li class="media">
            <div class="media-body">
            <strong class="media-heading"><a href="https://www.nature.com/articles/s41467-018-05016-8">Transcriptional synergy as an emergent property defining cell subpopulation identity enables population shift</a></strong>
            <p><small>Okawa S & Saltó C et al.</small></p>
             </div>
           </li>
         </div>
	
<p>&nbsp;</p>

         <li>
            <span class="post-date">June 25, 2018</span>
		  <span class="post-link">Original article in <u>Communications Biology</u> on role of Zeb2 in dopaminergic neurogenesis and migration</span>
          </li>
          <div class="well">
            <li class="media">
              <div class="media-body">
                <img class="pull-left" style="margin-right:10px;" src="/img/zeb2.jpg" height="300px";>
                  <strong class="media-heading"><a href="https://www.nature.com/articles/s42003-018-0080-0">A Zeb2-miR-200c loop controls midbrain dopaminergic neuron neurogenesis and migration</a></strong>
                <p><small>Yang S et al.</small></p>
                 <p>Zeb2 is a homeodomain transcription factor that plays pleiotropic functions during embryogenesis, but its role for midbrain dopaminergic (mDA) neuron development is unknown. Here we report that Zeb2 is highly expressed in progenitor cells in the ventricular zone of the midbrain floor plate and downregulated in postmitotic neuroblasts. Functional experiments show that Zeb2 expression in the embryonic ventral midbrain is dynamically regulated by a negative feedback loop that involves <i>miR-200c</i>. We also find that Zeb2 overexpression reduces the levels of CXCR4, NR4A2, and PITX3 in the developing ventral midbrain in vivo, resulting in migration and mDA differentiation defects. This phenotype was recapitulated by miR-200c knockdown, suggesting that the Zeb2-miR-200c loop prevents the premature differentiation of mDA progenitors into postmitotic cells and their migration. Together, our study establishes Zeb2 and miR-200c as critical regulators that maintain the balance between mDA progenitor proliferation and neurogenesis.
                </p>   
              </div>
            </li>
          </div>
<p>&nbsp;</p>	
		
        <li>
            <span class="post-date">April 25, 2018</span>
            <span class="post-link">NEWS: Division of Molecular Neurobiology has moved to the new Biomedicum building.<span>
        </li>
        <div class="well">
          <li class="media">
            <div class="media-body">
       		<blockquote class="twitter-tweet tw-align-center" data-lang="en"><p lang="en" dir="ltr">MolNeuro moving in at <a href="https://twitter.com/hashtag/Biomedicum?src=hash&amp;ref_src=twsrc%5Etfw">#Biomedicum</a>! <a href="https://twitter.com/slinnarsson?ref_src=twsrc%5Etfw">@slinnarsson</a> <a href="https://twitter.com/mandy_meijer?ref_src=twsrc%5Etfw">@mandy_meijer</a> <a href="https://twitter.com/dgyllborg?ref_src=twsrc%5Etfw">@dgyllborg</a> <a href="https://twitter.com/LarsBorm?ref_src=twsrc%5Etfw">@LarsBorm</a> <a href="https://twitter.com/GioeleLaManno?ref_src=twsrc%5Etfw">@GioeleLaManno</a> <a href="https://twitter.com/dvd_bruggen?ref_src=twsrc%5Etfw">@dvd_bruggen</a> <a href="https://twitter.com/UlrikaKatarina?ref_src=twsrc%5Etfw">@UlrikaKatarina</a> <a href="https://twitter.com/HjerlingLeffler?ref_src=twsrc%5Etfw">@HjerlingLeffler</a> <a href="https://twitter.com/D_eck_ard?ref_src=twsrc%5Etfw">@D_eck_ard</a>  <a href="https://t.co/CsHoVCZDw2">https://t.co/CsHoVCZDw2</a> <a href="https://t.co/ZAeqpmqgV3">pic.twitter.com/ZAeqpmqgV3</a></p>&mdash; GonçaloCasteloBranco (@GoCasteloBranco) <a href="https://twitter.com/GoCasteloBranco/status/989148231081824256?ref_src=twsrc%5Etfw">April 25, 2018</a></blockquote>
		<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>

                 <p></p>
               
	          <br>
	             <strong class="media-heading"><a href="http://ki.se/en/about/biomedicum-laboratory-of-the-future">More information: Biomedicum - Laboratory of the future</a></strong>
                  </p>
              </div>
            </li>
          </div>
           
<p>&nbsp;</p>
        
		
	<li>
          <span class="post-date">April 5, 2018</span>
          <span class="post-link">Collaborative article as Preprint at <u>BioRxiv</u> with the group of Sten Linnarsson on 
		    RNA sequencing of half a million cells in the mouse central nervous system</span>
        </li>
          <div class="well">
            <li class="media">
              <div class="media-body">
              <strong class="media-heading"><a href="https://www.biorxiv.org/content/early/2018/04/05/294918">Molecular Architecture of the Mouse Nervous System</a></strong>
              <p><small>Zeisel A et al.</small></p>
	      <p><a href="http://mousebrain.org/doku.php">Mousebrain.org</a>, wiki page for visualization of data</p>
               </div>
             </li>
           </div>
		
      <p>&nbsp;</p>	

	<li>
            <span class="post-date">March 1, 2018</span>
	    <span class="post-link"><b>Postdoctoral fellow position available</b> in Computational Biology of Single Cell and CRISPR Genomics</span>
        </li>
        <div class="well">
          <li class="media">
            <div class="media-body">
              <p>A postdoctoral fellow position is available in our lab. The position is in Computational Biology of Single Cell and CRISPR Genomics in Dopamine Neurons.</p>    
	      <p><a href="/img/Postdoctoral fellow_Computational Biology_EArenas.pdf">More information and announcement of position.</a></p>
	      <p><a href="https://ki.mynetworkglobal.com/en/what:job/jobID:196461/type:job/where:4/apply:1">Apply here!</a></p>
            </div>
          </li>
        </div>
		
      <p>&nbsp;</p>			

        <li>
            <span class="post-date">November 7, 2017</span>
            <span class="post-link">NEWS: Division of Molecular Neurobiology is moving in April 2018 to the new Biomedicum building.<span>
        </li>
        <div class="well">
          <li class="media">
            <div class="media-body">
               <div id="featureimage">
                 <img src="/img/bio.jpg"; align="middle"; width="600px";>
               </div>
                 <p></p>
                 <p>Karolinska Institutet is building an ultramodern, purpose-built facility for experimental medical research, 
                     Biomedicum. The new laboratory gives Karolinska Institutet more research space and new opportunities to make more 
                     effective use of shared infrastructure.
                     <br>
	             <br>
                     The department of MBB will be relocated to Biomedicum in April 2018.
                     <br>
	             <br>
	             <strong class="media-heading"><a href="http://ki.se/en/about/biomedicum-laboratory-of-the-future">More information: Biomedicum - Laboratory of the future</a></strong>
                  </p>
              </div>
            </li>
          </div>
           
<p>&nbsp;</p>

		
	  <li>
            <span class="post-date">August 23, 2017</span>
		  <span class="post-link">Original article in <u>Science Signaling</u> on role of YAP in dopaminergic differentiation and survival</span>
          </li>
          <div class="well">
            <li class="media">
              <div class="media-body">
                <img class="pull-left" style="margin-right:10px;" src="/img/scisig.gif" height="300px";>
                  <strong class="media-heading"><a href="http://stke.sciencemag.org/content/10/493/eaal4165">Niche-derived laminin-511 promotes midbrain dopaminergic neuron survival and differentiation through YAP</a></strong>
                <p><small>Zhang D, et al.</small></p>
                 <p>Parkinson’s disease (PD) is a neurodegenerative disorder marked by progressive loss of dopaminergic neurons and motor 
			 control. Various factors promote or inhibit neuronal survival. Zhang et al. found that a prosurvival signal was 
			 mediated by the transcription cofactor YAP. YAP was activated in midbrain dopaminergic neurons in culture and in 
			 mice through an interaction between an integrin and the extracellular matrix protein laminin-511. YAP then 
			 transcriptionally activated dopaminergic neuron differentiation factors and a microRNA that decreased the 
			 synthesis of the apoptotic protein PTEN. The findings uncover a new role for YAP in neurons and a pathway that 
			 might be explored for the purpose of promoting dopaminergic neuron survival in PD patients.
                </p>   
              </div>
            </li>
          </div>
<p>&nbsp;</p>
		
		<li>
          <span class="post-date">July 13, 2017</span>
          <span class="post-link">Original article in <u>Molecular Neurodegeneration</u> on binding partners of LRRK2</span>
        </li>
          <div class="well">
            <li class="media">
              <div class="media-body">
                <img class="pull-left" style="margin-right:10px;" src="/img/AS_lrrk2.jpg" height="300px";>
		<strong class="media-heading"><a href="https://molecularneurodegeneration.biomedcentral.com/articles/10.1186/s13024-017-0193-9">A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway</a></strong>
                <p><small>Salašová A, et al.</small></p>
                  <p>Autosomal-dominant mutations in the Park8 gene encoding Leucine-rich repeat kinase 2 (LRRK2) have been identified 
			  to cause up to 40% of the genetic forms of Parkinson’s disease. However, the function and molecular pathways 
			  regulated by LRRK2 are largely unknown. It has been shown that LRRK2 serves as a scaffold during activation of 
			  WNT/β-catenin signaling via its interaction with the β-catenin destruction complex, DVL1-3 and LRP6. In this 
			  study, we examine whether LRRK2 also interacts with signaling components of the WNT/Planar Cell Polarity 
			  (WNT/PCP) pathway, which controls the maturation of substantia nigra dopaminergic neurons, the main cell 
			  type lost in Parkinson’s disease patients.</p>
              </div>
            </li>
          </div>

		
          <p>&nbsp;</p>
		
          <li>
            <span class="post-date">July 3, 2017</span>
            <span class="post-link">Collaborative article with the group of Gunnar Schulte on Frizzled recruitment of Disheveled in <u>Cellular Signalling</u></span>
          </li>
          <div class="well">
            <li class="media">
              <div class="media-body">
              <strong class="media-heading"><a href="http://www.sciencedirect.com/science/article/pii/S0898656817301766">The tyrosine Y2502.39 in Frizzled 4 defines a conserved motif important for structural integrity of the receptor and recruitment of Disheveled</a></strong>
              <p><small>Strakova K et al.</small></p>
               </div>
             </li>
           </div>
		
<p>&nbsp;</p>
		
	  <li>
            <span class="post-date">June 26, 2017</span>
            <span class="post-link">Original article as Preprint at <u>BioRxiv</u> on the ventral midbrain dopaminergic niche<span>
          </li>
          <div class="well">
            <li class="media">
              <div class="media-body">
                <strong class="media-heading"><a href="http://biorxiv.org/content/early/2017/06/26/155846">Molecular analysis of the midbrain dopaminergic niche during neurogenesis</a></strong>
                  <p><small>Toledo EM, et al.</small></p>
                  <div id="featureimage">
                    <img src="/img/Niche_graphical.png"; align="middle"; width="600px";>
                  </div>
                  <p></p>
                  <p>Midbrain dopaminergic (mDA) neurons degenerate in Parkinson's disease and are one of the main targets for cell replacement 
		       therapies. However, a comprehensive view of the signals and cell types contributing to mDA neurogenesis is not yet 
		       available. By analyzing the transcriptome of the mouse ventral midbrain at a tissue and single-cell level during mDA 
		       neurogenesis we found that three recently identified radial glia types 1-3 (Rgl1-3) contribute to different key aspects 
		       of mDA neurogenesis. While Rgl3 expressed most extracellular matrix components and multiple ligands for various 
		       pathways controlling mDA neuron development, such as Wnt and Shh, Rgl1-2 expressed most receptors. Moreover, we found 
		       that specific transcription factor networks explain the transcriptome and suggest a function for each individual radial 
		       glia. A network controlling neurogenesis was found in Rgl1, progenitor maintenance in Rgl2 and the secretion of factors 
		       forming the mDA niche by Rgl3. Our results thus uncover a broad repertoire of developmental signals expressed by each 
		       midbrain cell type during mDA neurogenesis. Cells identified for their emerging importance are Rgl3, a niche cell type, 
		       and Rgl1, a neurogenic progenitor that expresses ARNTL, a transcription factor that we find is required for mDA 
		       neurogenesis.</p>
              </div>
            </li>
          </div>
           
<p>&nbsp;</p>
    
		<li>
            <span class="post-date">May 26, 2017</span>
            <span class="post-link">Review article on Wnts in human development in <u>British Journal of Pharmacology</u></span>
          </li>
          <div class="well">
            <li class="media">
              <div class="media-body">
                <strong class="media-heading"><a href="http://onlinelibrary.wiley.com/doi/10.1111/bph.13871/full">Translation of WNT developmental programs into stem cell replacement strategies for the treatment of Parkinson's disease</a></strong>
                <p><small>Toledo EM, Gyllborg D, and Arenas E</small></p>
              </div>
             </li>
           </div>
		
<p>&nbsp;</p>		
		
          <li>
            <span class="post-date">May 9, 2017</span>
            <span class="post-link"><u>Nature Biotechnology</u> has a <i>News and Views</i> article about our recent publication on reprogramming astrocytes</span>
          </li>
          <div class="well">
            <li class="media">
              <div class="media-body">
	        <div id="featureimage">
	          <img src="/img/nbt_news.jpg"; align="middle"; width="600px";>
		</div>
		<p></p>
                <strong class="media-heading"><a href="http://www.nature.com/nbt/journal/v35/n5/full/nbt.3869.html">Reprogramming the diseased brain</a></strong>
		  <p><small>Dunnett SB and Rosser AE</small></p>
		  <p></p>
		  <small>Original publication by Rivetti di Val Cervo P, et al.</small><br>
                  <a href="https://www.nature.com/nbt/journal/v35/n5/full/nbt.3835.html">Link to original publication</a>
	        </div>
              </li>
            </div>
		    
  <p>&nbsp;</p>
		
		
          <li>
            <span class="post-date">April 19, 2017</span>
            <span class="post-link">Collaborative article with the group of Per Uhlén on mapping genes for calcium signaling in <u>Bioinformatics</u></span>
          </li>
          <div class="well">
            <li class="media">
              <div class="media-body">
              <strong class="media-heading"><a href="https://academic.oup.com/bioinformatics/article/3740048/Mapping-Genes-for-Calcium-Signaling-and-Their?searchresult=1">Mapping Genes for Calcium Signaling and Their Associated Human Genetic Disorders</a></strong>
              <p><small>Hörtenhuber M. et al.</small></p>
               </div>
             </li>
           </div>
		
		
    <p>&nbsp;</p>

		
          <li>
            <span class="post-date">April 17, 2017</span>
            <span class="post-link">Collaborative article with the group of Igor Adameyko on growth and shaping of vertebrate cartilage in <u>eLife</u></span>
          </li>
          <div class="well">
            <li class="media">
              <div class="media-body">
                <strong class="media-heading"><a href="https://elife.elifesciences.org/content/6/e25902">Oriented clonal cell dynamics enables accurate growth and shaping of vertebrate cartilage</a></strong>
                <p><small>Kaucka M. et al.</small></p>
              </div>
             </li>
           </div>
		
           <p>&nbsp;</p>
			
	  <li>
            <span class="post-date">April 10, 2017</span>
		  <span class="post-link">Original article in <u>Nature Biotechnology</u> on reprogrammed astrocytes to dopaminergic neurons</span>
          </li>
          <div class="well">
            <li class="media">
              <div class="media-body">
                <img class="pull-left" style="margin-right:10px;" src="/img/nbtc.gif" height="300px";>
		<strong class="media-heading"><a href="http://www.nature.com/nbt/journal/vaop/ncurrent/full/nbt.3835.html">Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model</a></strong>
                <p><small>Rivetti di Val Cervo P, et al.</small></p>
                  <p>Cell replacement therapies for neurodegenerative disease have focused on transplantation of the cell 
			  types affected by the pathological process. Here we describe an alternative strategy for Parkinson's 
			  disease in which dopamine neurons are generated by direct conversion of astrocytes. Using three 
			  transcription factors, NEUROD1, ASCL1 and LMX1A, and the microRNA miR218, collectively designated 
			  NeAL218, we reprogram human astrocytes in vitro, and mouse astrocytes in vivo, into induced dopamine 
			  neurons (iDANs). Reprogramming efficiency in vitro is improved by small molecules that promote 
			  chromatin remodeling and activate the TGFβ, Shh and Wnt signaling pathways. The reprogramming 
			  efficiency of human astrocytes reaches up to 16%, resulting in iDANs with appropriate midbrain 
			  markers and excitability. In a mouse model of Parkinson's disease, NeAL218 alone reprograms adult striatal 
			  astrocytes into iDANs that are excitable and correct some aspects of motor behavior in vivo, including gait 
			  impairments. With further optimization, this approach may enable clinical therapies for Parkinson's disease 
			  by delivery of genes rather than cells.</p>
              <p><a href="http://ki.se/en/news/conversion-of-brain-cells-offers-hope-for-parkinsons-patients">News article at Karolinska Institutet</a></p>
                <p><a href="http://www.the-scientist.com/?articles.view/articleNo/49167/title/Reprogrammed-Glia-Improve-Symptoms-in-a-Mouse-Model-of-Parkinson-s/">Press article in TheScientist</a></p>
              <p><a href="https://www.scientificamerican.com/article/cell-therapy-2-0-reprogramming-the-brain-rsquo-s-own-cells-for-parkinson-rsquo-s-treatment/">Press article in Scientific American</a></p>
		    </div>
            </li>
          </div>

		
          <p>&nbsp;</p>
		
		
          <li>
            <span class="post-date">October 6, 2016</span>
		  <span class="post-link">Original article in <u>Cell</u> on single-cell in the developing ventral midbrain</span>
          </li>
          <div class="well">
            <li class="media">
              <div class="media-body">
                <img class="pull-left" style="margin-right:10px;" src="/img/Cell_GraphicalAbstract.jpg" height="300px";>
                  <strong class="media-heading"><a href="http://www.cell.com/cell/fulltext/S0092-8674(16)31309-5">Molecular Diversity of Midbrain Development in Mouse, Human, and Stem Cells</a></strong>
                <p><small>La Manno G, Gyllborg D, et al.</small></p>
                  <p>Understanding human embryonic ventral midbrain is of major interest for Parkinson’s disease. However, the cell types, 
                   their gene expression dynamics, and their relationship to commonly used rodent models remain to be defined. We performed 
                   single-cell RNA sequencing to examine ventral midbrain development in human and mouse. We found 25 molecularly defined 
                   human cell types, including five subtypes of radial glia-like cells and four progenitors. In the mouse, two mature fetal 
                   dopaminergic neuron subtypes diversified into five adult classes during postnatal development. Cell types and gene 
                   expression were generally conserved across species, but with clear differences in cell proliferation, developmental 
                   timing, and dopaminergic neuron development. Additionally, we developed a method to quantitatively assess the fidelity of 
                   dopaminergic neurons derived from human pluripotent stem cells, at a single-cell level. Thus, our study provides insight 
                   into the molecular programs controlling human midbrain development and provides a foundation for the development of cell 
                   replacement therapies.</p>
                <p><a href="https://kiedit.ki.se/en/news/midbrain-study-gives-boost-to-parkinsons-research">News article at Karolinska Institutet</a></p>
                <p><a href="http://linnarssonlab.org/ventralmidbrain">Supporing Information and Visualization</a></p>
              </div>
            </li>
          </div>
          <p>&nbsp;</p>
          
          <li>
            <span class="post-date">September 15, 2016</span>
		  <span class="post-link">Original article in <u>EMBO</u> on role of Pbx1 in the ventral midbrain</span>
          </li>
          <div class="well">
            <li class="media">
              <div class="media-body">
                <img class="pull-left" style="margin-right:10px;" src="/img/PBX.jpg" height="300px";>
                  <strong class="media-heading"><a href="http://emboj.embopress.org/content/35/18/1963">A PBX1 transcriptional network controls dopaminergic neuron development and is impaired in Parkinson's disease</a></strong>
                <p><small>Villaescusa JC, et al.</small></p>
                 <p>Pre‐B‐cell leukemia homeobox (PBX) transcription factors are known to regulate organogenesis, but their molecular targets 
              and function in midbrain dopaminergic neurons (mDAn) as well as their role in neurodegenerative diseases are unknown. Here, 
              we show that PBX1 controls a novel transcriptional network required for mDAn specification and survival, which is sufficient 
              to generate mDAn from human stem cells. Mechanistically, PBX1 plays a dual role in transcription by directly repressing or 
              activating genes, such as Onecut2 to inhibit lateral fates during embryogenesis, Pitx3 to promote mDAn development, and 
              Nfe2l1 to protect from oxidative stress. Notably, PBX1 and NFE2L1 levels are severely reduced in dopaminergic neurons of the 
              substantia nigra of Parkinson's disease (PD) patients and decreased NFE2L1 levels increases damage by oxidative stress in 
              human midbrain cells. Thus, our results reveal novel roles for PBX1 and its transcriptional network in mDAn development and 
              PD, opening the door for new therapeutic interventions.
                </p>
              </div>
            </li>
          </div>
	  <p>&nbsp;</p>

<!-- End news section -->

<!-- Start 'About the lab' section -->
      </ul>
      <div class="news">	      
        <h2>About the lab:</h2>
	  <ul class="posts">	
            <p>The Arenas Laboratory aims at developing regenerative therapies for Parkinson's disease. Work in this area integrates molecular, 
          cellular, and biochemical techniques, and involves both in vitro and in vivo studies. Of particular interest are specific aspects 
          of midbrain and dopamine neuron development, Wnt signaling, biotechnology, stem cell biology and regenerative medicine for 
          Parkinson's disease.</p>
            <p>At Karolinska Institutet, the laboratory is situated in the new Biomedicum building as part of the Division of Molecular Neurobiology 
		    within the Department of Medical Biochemistry and Biophysics (MBB). MBB is a department consisting of 12 research divisions  
		    within the fields of protein chemistry, redox biochemistry, metabolism, lipid research, inflammation research, structural 
		    biochemistry, molecular biochemistry, tissue biology, and developmental biology. </p>
            <p>Karolinska Institutet is Sweden’s single largest centre of medical academic research and one of the world’s foremost medical 
		    universities with a vision is to make a significant contribution to the improvement of human health. Since 1901 the 
		    Nobel Assembly at Karolinska Institutet awards the Nobel prize in Physiology or Medicine.
	    </p>
	  </ul>
        </div>
<p>&nbsp;</p>
<!-- Start 'Contact' section -->	      
    <hr>

      <div class="news">
        <p>&nbsp;</p>
        <h2>Contact Information</h2>
	<ul class="posts">
	  <div class="row">
	    <div class=" col-sm-4  col-md-4 col-lg-4" align="left">  
              <h4>Visiting address:</h4>
                <p>Karolinska Institutet<br>
                   Biomedicum, C6<br>
                   Solnavägen 9<br>
                   171 65 Solna, Sweden</p>
                   <a href="https://www.google.com/maps/place/Solnav%C3%A4gen+9,+171+65+Solna/@59.3497337,18.0233539,17z/data=!3m1!4b1!4m5!3m4!1s0x465f9d9c18ba64f7:0xd8d92683a7bdfd6d!8m2!3d59.3497337!4d18.0255426" target="_blank"> <img style='width: 30%; object-fit: contain' src="img/mapsicon.jpg" border="0" alt=""> </a> 
            </div>
	    <div class=" col-sm-4  col-md-4 col-lg-4" align="left">
	      <h4>Mailing address:</h4>
                <p>Karolinksa Institutet<br>
                   171 77 Stockholm, Sweden</p>	
	    </div> 
	    <div class=" col-sm-4  col-md-4 col-lg-4" align="left">
	      <h4>For deliveries:</h4>
                <p>Karolinska Institutet<br>
		   Biomedicum, C6<br>
                   Tomtebodavägen 16<br>
                   171 65 Solna, Sweden</p>	
	    </div>
            
          </div>
	</ul>
      </div> 
	

		
<!-- End 'Contact' section -->		
      	
    </div>
   </div>
  </div>
  <p>&nbsp;</p>
  


<!-- Footer section -->	
	
  <footer class="footer">
    <div class="wrapfoot">
      <div class="row">
	<div class=" col-sm-4  col-md-3 col-lg-3">
          <ul>
            <li>Ernest Arenas Lab</li>
            <li><a href="mailto:ernest.arenas@ki.se">ernest.arenas@ki.se</a></li>
          </ul>
        </div>
        <div class=" col-sm-8  col-md-9 col-lg-9" align="right">
	  <ul>
            <li><a href="https://ki.se/en/mbb/research-division-of-molecular-neurobiology">Division of Molecular Neurobiology</a></li>
            <li><a href="https://ki.se/en/mbb/startpage">Department of Medical Biochemistry and Biophysics</a></li>
            <li><a href="http://ki.se/en/startpage">Karolinska Institutet</a></li>
          </ul>   
        </div>   
      </div>
      <div class="row">
	<div class=" col-sm-4  col-md-4 col-lg-4">  
        </div>
        <div class=" col-sm-4  col-md-4 col-lg-4" align="center">
		<p>Updated: October 24, 2023</p>
	</div>   
        <div class=" col-sm-4  col-md-4 col-lg-4">
	</div>
      </div>
    </div>
  </footer>
	
<!-- End footer -->	

	



</body>
</html>

